Martin Shkreli, 10% Owner at KALOBIOS PHARMACEUTICALS INC (KBIO), bought 440,000 shares at $2.02 ($889K) on 2015-11-18, disclosed to the SEC on 2015-11-19.
Open-market purchase of $889k KBIO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| KBIO | BUY | 2015-11-23 | $94K | — | Filing → |
| KBIO | BUY | 2015-11-18 | $1.6M | — | Filing → |
| RTRX | SELL | 2014-11-24 | $10.4M | — | Filing → |